Review of gemcitabine in biliary tract carcinoma

被引：56
作者：
Scheithauer, W [1 ]
机构：
[1] Univ Vienna, Dept Internal Med 1, Div Oncol, Sch Med, A-1090 Vienna, Austria
来源：
SEMINARS IN ONCOLOGY | 2002年 / 29卷 / 06期
关键词：
D O I：
10.1016/S0093-7754(02)70025-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：40 / 45
页数：6
相关论文
共 39 条
  • [11] DOVAL DC, 2001, P AN M AM SOC CLIN, V20, pA156
  • [12] Eng C, 2000, J INVEST MED, V48, p266A
  • [13] Supraadditive effect of 2′,2′-difluorodeoxycytidine (gemcitabine) in combination with oxaliplatin in human cancer cell lines
    Faivre, S
    Raymond, E
    Woyarowski, JM
    Cvitkovic, E
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1999, 44 (02) : 117 - 123
  • [14] Maximum-tolerated dose defined for single-agent gemcitabine: A phase I dose-escalation study in chemotherapy-naive patients with advanced non-small-cell lung cancer
    Fossella, FV
    Lippman, SM
    Shin, DM
    Tarassoff, P
    CalayagJung, M
    PerezSoler, R
    Lee, JS
    Murphy, WK
    Glisson, B
    Rivera, E
    Hong, WK
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (01) : 310 - 316
  • [15] GALLARDO J, 2000, P AN M AM SOC CLIN, V19, pA1042
  • [16] Treatment of inoperable and/or metastatic biliary tree carcinomas with single-agent gemcitabine or in combination with levofolinic acid and infusional fluorouracil: Results of a multicenter phase II study
    Gebbia, V
    Giuliani, F
    Maiello, E
    Colucci, G
    Verderame, F
    Borsellino, N
    Mauceri, G
    Caruso, M
    Tirrito, ML
    Valdesi, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (20) : 4089 - 4091
  • [17] Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a randomised multicentre trial
    Georgoulias, V
    Papadakis, E
    Alexopoulos, A
    Tsiafaki, X
    Rapti, A
    Veslemes, M
    Palamidas, P
    Vlachonikolis, I
    [J]. LANCET, 2001, 357 (9267) : 1478 - 1484
  • [18] GODEFRIDUS JP, 1995, SEMIN ONCOL S11, V22, P1
  • [19] Cancer statistics, 2001
    Greenlee, RT
    Hill-Harmon, MB
    Murray, T
    Thun, M
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2001, 51 (01) : 15 - 36
  • [20] HEINEMANN V, 1990, MOL PHARMACOL, V38, P567
1234